MedTrace Logo

Anti-inflammatory Effect and Associated Mechanisms of Mango Consumption

NCT04726293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-05-11

No results posted yet for this study

Summary

The primary objective of this project is to provide new knowledge through a comprehensive set of analyses that investigate the complex interplay between regular mango intake, gut microbial structure/ function, mechanisms of inflammation and insulin sensitivity in over weight (OW)/obese (OB) human subjects with chronic low-grade inflammation.

Conditions

  • Overweight or Obesity
  • Healthy

Interventions

DIETARY_SUPPLEMENT

Mango

Mango beverage -1 cup fresh mango equivalent, twice a day for 4 weeks

DIETARY_SUPPLEMENT

Control

control beverage 1 cup, twice a day for 4 weeks

Sponsors & Collaborators

  • Food and Drug Administration (FDA)

    collaborator FED

  • Clinical Nutrition Research Center, Illinois Institute of Technology

    lead INDUSTRY

Principal Investigators

  • Indika v, Ph.D · Illinois Insititute of Technology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-22
Primary Completion
2023-03-31
Completion
2025-04-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04726293 on ClinicalTrials.gov